Combination checkpoint blockade--taking melanoma immunotherapy to the next level
- PMID: 23724866
- DOI: 10.1056/NEJMe1305484
Combination checkpoint blockade--taking melanoma immunotherapy to the next level
Comment on
-
Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma.N Engl J Med. 2013 Jul 11;369(2):134-44. doi: 10.1056/NEJMoa1305133. Epub 2013 Jun 2. N Engl J Med. 2013. PMID: 23724846 Free PMC article. Clinical Trial.
-
Nivolumab plus ipilimumab in advanced melanoma.N Engl J Med. 2013 Jul 11;369(2):122-33. doi: 10.1056/NEJMoa1302369. Epub 2013 Jun 2. N Engl J Med. 2013. PMID: 23724867 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical